RhAPPcast
Episodes
FAQ: How Does Weight Reduction Impact PsA Outcomes?
16 Apr 2026
Contributed by Lukas
In this educational video, Shannon Ghizzoni, a physician assistant at Columbus Arthritis Center, explores the impact of weight reduction on disease ac...
FAQ: What Are the Neuromuscular and Functional Burdens of Living With HPP?
14 Apr 2026
Contributed by Lukas
In this FAQ video, Jeremy Morgan, NP, from Access Solutions Rheumatology in Tulsa, Oklahoma, discusses the neuromuscular and functional burden of hypo...
RhAPPcast: IVIG Unpacked
11 Apr 2026
Contributed by Lukas
In this episode of RhAPPcast, Amanda Mixon, PA-C, and Laura Hoover, PharmD, break down the clinical use of intravenous immunoglobulin (IVIG) in rheuma...
Journal Club Review: DISCOVER-2 Severe PsA Publication
09 Apr 2026
Contributed by Lukas
In this journal club review module, Danielle Gatti Palumbo, PharmD, explores a post hoc analysis of a phase 3 clinical trial evaluating the efficacy o...
FAQ: How Does Obesity Affect PsA Outcomes?
07 Apr 2026
Contributed by Lukas
In this FAQ, Libby Allen, a rheumatology nurse practitioner, explains how obesity impacts psoriatic arthritis outcomes and why it plays a critical rol...
RhAPPcast: IVIG Unpacked
04 Apr 2026
Contributed by Lukas
In this episode of RhAPPcast, Amanda Mixon, PA-C, and Laura Hoover, PharmD, break down the clinical use of intravenous immunoglobulin (IVIG) in rheuma...
FAQ: What Skeletal and Dental Manifestations Might Indicate HPP?
02 Apr 2026
Contributed by Lukas
In this educational FAQ video, Jeremy Morgan, NP, of Access Solutions Rheumatology in Tulsa, Oklahoma, explores the key skeletal and dental manifestat...
RhAPPcast: SubQ Solutions: Induction and Maintenance in Moderately to Severely Active CD and UC
31 Mar 2026
Contributed by Lukas
In this episode of RhAPPcast, host Amanda Mixon, PA-C, is joined by Christina Hanson, FNP-C, to explore the growing intersection between rheumatology ...
RhAPPcast: Upadacitinib in GCA: Interpreting the 2-Year SELECT-GCA Results
26 Mar 2026
Contributed by Lukas
Stay up to date on the latest advances in giant cell arteritis (GCA) management with this Fireside Chat episode featuring expert insights from Naomi A...
FAQ: What is the Importance of MRI in Assessing Axial Disease Manifestations in PsA?
24 Mar 2026
Contributed by Lukas
In this video, rheumatology physician assistant Amanda Mixon, PA-C, discusses the critical role of MRI in identifying axial involvement in psoriatic a...
FAQ: How Does Obesity Impact the Immune System?
19 Mar 2026
Contributed by Lukas
Obesity can significantly impact immune system function and contribute to chronic inflammation. In this educational segment, rheumatology nurse practi...
FAQ: What Role Does Power Doppler Ultrasound Play in Detecting Subclinical Inflammation/Enthesitis?
17 Mar 2026
Contributed by Lukas
Power Doppler ultrasound is transforming how clinicians detect subclinical enthesitis in conditions like psoriatic arthritis (PsA) and spondyloarthrit...
RhAPPcast: Unpacking the Genetics: Low ALP
12 Mar 2026
Contributed by Lukas
In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon sits down with rheumatology PA Heath...
FAQ: What Is the Efficacy of Switching MOA to Guselkumab After Inadequate Response to a single TNFi?
10 Mar 2026
Contributed by Lukas
In this FAQ video, Will Saalfeld, NP, reviews the clinical efficacy of switching to guselkumab after an inadequate response to a TNF inhibitor in psor...
Podcast: Inflammation Intersection: A Rheum-Gi Dialogue
05 Mar 2026
Contributed by Lukas
In this episode of RhAPPcast, host Amanda Mixon, PA-C, leads a 2026 Fireside Chat exploring the intersection of rheumatology and gastroenterology. Joi...
RhAPPcast: Protecting Joints: Inhibiting Structural Damage in PsA With Guselkumab
03 Mar 2026
Contributed by Lukas
In this RhAPPcast episode, host Amanda Mixon, PA-C, is joined by Wendy Simmons, PA-C, to discuss the role of guselkumab in inhibiting structural damag...
FAQ: How Can Clinicians Best Approach Talking to Patients With PsA About Weight Management?
26 Feb 2026
Contributed by Lukas
In this FAQ video, Iris Zink, MSN, ANP-BC, RN-BC, shares practical strategies for discussing weight management with patients living with psoriatic art...
Med Review: What is the Safety and Efficacy Profile of Guselkumab in Juvenile Psoriatic Arthritis?
25 Feb 2026
Contributed by Lukas
In this updated medication review video module, Brandon Ko, DNP, and Pediatric Chair of RhAPP, reviews the recent FDA approval of guselkumab for juven...
Medication Review: Anti-Drug Antibody Development With Guselkumab in Psoriasis, PsA & IBD
24 Feb 2026
Contributed by Lukas
In this Medication Review, Lisa Asfahani, PA-C, discusses anti-drug antibody development and immunogenicity associated with guselkumab in the treatmen...
FAQ: What Role Does Tissue-Nonspecific Alkaline Phosphatase (TNSALP) Play in HPP?
19 Feb 2026
Contributed by Lukas
In this FAQ video, RhAPP board member Heather Mambretti, PA-C, explains the critical role of tissue-nonspecific alkaline phosphatase (TNSALP) in hypop...
Medication Review: Laboratory Monitoring for Guselkumab in Psoriasis, PsA, and IBD
17 Feb 2026
Contributed by Lukas
In this Medication Review, Lisa Asfahani, PA-C, shares practical laboratory monitoring recommendations for guselkumab across psoriasis, psoriatic arth...
Podcast: Inflammation Amplified: Understanding the PsA—Obesity Connection
12 Feb 2026
Contributed by Lukas
In this episode of RhAPPcast, the official podcast of rheumatology advanced practice providers, we explore the complex and often underrecognized relat...
Medication Review: Safety and Efficacy of Guselkumab in Crohn’s Disease and Ulcerative Colitis
10 Feb 2026
Contributed by Lukas
In this Medication Review, Kimberly Orleck, PA-C, reviews the efficacy and safety data for guselkumab in moderate to severe ulcerative colitis and Cro...
Across The Rheum Podcast: Part 3 - Clinical Utility and Positioning of IL-23 Agents
06 Feb 2026
Contributed by Lukas
In Part 3 of the Across the Rheum podcast series, Dr. Sergio Schwartzman concludes the three-part discussion on the IL-23 paradigm in psoriatic arthri...
Podcast: Under the Surface: Exploring the HPP Diagnosis in Adulthood
05 Feb 2026
Contributed by Lukas
Hypophosphatasia (HPP) is a rare genetic bone disorder that is often overlooked in adults, leading to years of misdiagnosis and ineffective treatment....
FAQ: Screening Tools APPs Use to Identify PsA, SpA, or IBD and Refer Early
03 Feb 2026
Contributed by Lukas
Delayed diagnosis in psoriatic arthritis (PsA), spondyloarthritis (SpA), and inflammatory bowel disease (IBD) can lead to irreversible damage and prol...
FAQ: What Validated Screening Tools Identify PsA/SpA or IBD for Rheumatology or GI Referral?
03 Feb 2026
Contributed by Lukas
In this FAQ video, Audrey Gibson, PA-C, reviews validated screening tools used to identify psoriatic arthritis, spondyloarthritis, and inflammatory bo...
Across The Rheum Podcast: Part 2 - Currently Available IL-23 Agents
30 Jan 2026
Contributed by Lukas
In Part 2 of the Across the Rheum podcast series, host Dr. Sergio Schwartzman continues the three-part discussion on the IL-23 paradigm in psoriatic a...
Journal Club: HPP Diagnosis—Current State of the Art & Proposed Criteria for Children and Adults
29 Jan 2026
Contributed by Lukas
In this Journal Club episode, Holly Reid, PA-C reviews the 2023 Osteoporosis International article, Hypophosphatasia Diagnosis: Current State of the A...
Med Review: What is the Safety and Efficacy Profile of Guselkumab in Juvenile Psoriatic Arthritis?
27 Jan 2026
Contributed by Lukas
Brandon Ko, NP, a pediatric rheumatology nurse practitioner at the University of New Mexico and Pediatric Chair for RhAPP, reviews the potential role ...
Across The Rheum Podcast: Part 1: Immunology of IL-23
23 Jan 2026
Contributed by Lukas
Welcome to the premiere of Across the Rheum, the official podcast of Rheum Connect, where cutting-edge science meets real-world clinical insight in rh...
RhAPPcast: Born with Burden: Understanding the Pediatric Presentation of HPP
22 Jan 2026
Contributed by Lukas
In this episode of RhAPPcast, host Amanda Mixon, President of RhAPP, is joined by pediatric rheumatology specialist and RhAPP board member Brandon Ko ...
RhAPPcast: Unpacking the Differences: IL-23 Inhibitors in Focus
20 Jan 2026
Contributed by Lukas
In this episode of RhAPPcast, host Amanda Mixon, President of RhAPP, is joined by rheumatology PA Audrey Gibson for an in-depth discussion on IL-23 in...
FAQ: What is Hypophosphatasia and How Does It Present Across the Lifespan?
15 Jan 2026
Contributed by Lukas
In this FAQ, Brandon Ko, APRN, a pediatric rheumatology nurse practitioner and RhAPP Pediatric Chair, provides a practical overview of hypophosphatasi...
Journal Club: Guselkumab Binds To CD64+ IL-23–Producing Myeloid Cells to Neutralize IL-23 Signals
13 Jan 2026
Contributed by Lukas
In this journal club review, clinical pharmacist Danielle Gatti Palumbo, breaks down a March 2025 study examining how guselkumab’s unique Fc-domain ...
FAQ: How Is Hypophosphatasia Diagnosed and What Are the Key Laboratory Markers?
08 Jan 2026
Contributed by Lukas
In this focused educational video, Heather Mambretti, PA-C, a rheumatology APP with over 12 years of experience and a faculty and board member for RhA...
What Is the Correlation of CD64 and IL-23 Expression in Inflamed Joint, Skin, and Gut Tissue?
06 Jan 2026
Contributed by Lukas
In this video, Lindsay Tom, PA-C, takes a focused look at the emerging connection between CD64 and IL-23 across inflamed joint, skin, and gut tissue. ...
FAQ: What is the Normal Role of CD64 in Innate and Adaptive Immunity?
23 Dec 2025
Contributed by Lukas
In this educational rheumatology video, physician assistant Lindsay Tom, PA-C, from the Northern Virginia Center for Arthritis, provides a clear and c...
Podcast: A Tale of Two Pediatric APPs
19 Dec 2025
Contributed by Lukas
In this short video, pediatric rheumatology advanced practice providers Brandon Ko, APRN, DNP, C-PNP, and Brandi Goble, PNP, share their personal jour...
Medication Review: Describe the Dual Mechanism of Action of Guselkumab
16 Dec 2025
Contributed by Lukas
In this video, Audrey Gibson, PA-C, a rheumatology physician assistant with nearly two decades of clinical experience, breaks down the unique dual mec...
FAQ: Why is the mvdH-S Score Used Most Often in PsA Trials?
11 Dec 2025
Contributed by Lukas
In this FAQ, William Saalfeld, NP, breaks down why the modified van der Heijde–Sharp (mvdH-S) score remains the most widely used radiographic method...
FAQ: How Does The Design of APEX Differ From DISCOVER-2 To Enrich For Structural Damage?
09 Dec 2025
Contributed by Lukas
Discover how the APEX trial raised the bar in understanding structural damage risk in psoriatic arthritis. In this quick FAQ video module, William Saa...
The Conversation That Matters: Talking to Patients About Obesity and IMIDs
01 Dec 2025
Contributed by Lukas
In this final episode of our RhAPP, MAPP, GHAPP, and SDPA crosscast series, expert APPs from dermatology, gastroenterology, rheumatology, and obesity ...
From Insight to Action: Practical Strategies to Improve Outcomes in Patients with Obesity and IMIDs
24 Nov 2025
Contributed by Lukas
In this cross-specialty episode of our RhAPP, GHAPP, MAPP and SDPA collaborative series, leading APPs from dermatology, gastroenterology, rheumatology...
The Hidden Costs: Obesity’s Role in Suboptimal Outcomes and Healthcare Burden in IMIDs
17 Nov 2025
Contributed by Lukas
In this episode of our crosscast series shared across RhAPPcast, GHAPPcast, and Dermcast, we explore the hidden costs of obesity in immune-mediated in...
Obesity and IMIDs: Unpacking the Epidemic and Its Far-Reaching Impacts
10 Nov 2025
Contributed by Lukas
Welcome to the first episode in our special cross-platform podcast collaboration on IMIDs and Obesity, shared across RhAPPcast, GHAPPcast, and Dermcas...
Live from RhAPP National: ILD & PH-ILD at the Rheum–Pulm Crossroads
06 Nov 2025
Contributed by Lukas
Join host Amanda Mixon, President of RhAPP, for a special episode of RhAPPcast, recorded live at the 6th Annual RhAPP Conference. In this conversation...
RhAPPcast: ANCA-Associated Vasculitis: Insights From the RhAPP National Conference
03 Nov 2025
Contributed by Lukas
Join host Amanda Mixon, PA-C, live from the 6th Annual RhAPP National Conference in Denver, as she sits down with Naomi Amudala, CRNP, from Penn Medic...
FAQ: What is the clinical significance of structural damage in PsA?
30 Oct 2025
Contributed by Lukas
In this educational segment, Wendy Simmons, PA-C, from Carolina Arthritis Associates in Wilmington, North Carolina, shares her nearly three decades of...
Medication Review: Evidence for Guselkumab in Preventing Structural Damage Progression
28 Oct 2025
Contributed by Lukas
In this medication review, Wendy Simmons, PA-C, from Carolina Arthritis Associates in Wilmington, North Carolina, draws on nearly three decades of rhe...
RhAPPcast: Beyond Dryness: Key Takeaways from the Sjögren’s Symposium at RhAPP 2025
21 Oct 2025
Contributed by Lukas
Welcome to RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers. In this episode, hosted by Amanda Mixon, PA-C, current RhAPP P...
FAQ: What is the Effect of Guselkumab on Structural Damage in PsA?
16 Oct 2025
Contributed by Lukas
In this episode, Wendy Simmons, PA-C from Carolina Arthritis in Wilmington, North Carolina, shares insights from nearly three decades of rheumatology ...
FAQ: What is the Inflation Reduction Act & How Does It Impact Affordability of Biologic Therapies?
14 Oct 2025
Contributed by Lukas
In this episode, Kyle George, PA-C at St. Luke’s Rheumatology in Idaho, explains the Inflation Reduction Act of 2022 and its impact on the affordabi...
RhAPPcast: Unmasking XLH: Misdiagnosed and Misunderstood
09 Oct 2025
Contributed by Lukas
In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, is joined by Bonnie Smeryage,...
RhAPPcast: Refractory PMR: When Steroids Aren’t Enough – Unmet Needs in Treatment
07 Oct 2025
Contributed by Lukas
In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, is joined by Claudia Rivera S...
RhAPPcast: The Safety Conversation: Upadacitinib in the Treatment of GCA
02 Oct 2025
Contributed by Lukas
In this final episode of the GCA Fireside Chat series on RhAPPcast, host Amanda Mixon, PA-C, is joined again by Naomi Amudala, CRNP, and Jessica Farre...
Medication Review: What is the safety profile of sarilumab in PMR & RA?
30 Sep 2025
Contributed by Lukas
In this expert-led video, Heather Mambretti, PA-C, who has over 13 years of experience in rheumatology, reviews the safety profile of sarilumab for pa...
RhAPPcast: Expanding the Arsenal: JAK Inhibitors in the Evolving GCA Landscape
18 Sep 2025
Contributed by Lukas
Welcome to RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers. In this fourth episode of our GCA Fireside Chat series, host A...
Medication Review: How is Sarilumab Dosed & Administered for the Treatment of PMR & RA?
16 Sep 2025
Contributed by Lukas
In this educational video, Heather Mambretti, PA-C with over 13 years of rheumatology experience, explains how sarilumab is dosed and what patients ca...
Medication Review: Key Patient Education When Starting Sarilumab for PMR or RA
09 Sep 2025
Contributed by Lukas
Starting a new biologic can be overwhelming for patients with polymyalgia rheumatica (PMR) or rheumatoid arthritis (RA). In this medication review, He...
RhAPPcast: Inside the Evidence: A Deep Dive into the SELECT-GCA Study
04 Sep 2025
Contributed by Lukas
In this episode of RhAPPcast, the official podcast of rheumatology advanced practice providers, host Amanda Mixon continues the GCA Fireside Chat seri...
RhAPPcast: Laying the Foundation: Historical Approaches to GCA Treatment
02 Sep 2025
Contributed by Lukas
Welcome back to RhAPPcast, the official podcast of rheumatology advanced practice providers. In this episode, host Amanda Mixon continues the GCA Fire...
FAQ: What is the Role of Sarilumab in Managing PMR?
02 Sep 2025
Contributed by Lukas
In this video, Claudia Rivera Salas, NP, a rheumatology nurse practitioner in East Lansing, Michigan, discusses the role of sarilumab in the managemen...
Journal Club: Comparative Effectiveness of Sarilumab vs. Methotrexate as a Corticosteroid-Sparing Agent in Patients with Polymyalgia Rheumatica
26 Aug 2025
Contributed by Lukas
In this Journal Club discussion, Jeannette Hart, PA-C, reviews the landmark SAPHYR trial evaluating sarilumab for patients with polymyalgia rheumatica...
FAQ: Choosing Between Steroid-Sparing Agents in PMR Treatment
19 Aug 2025
Contributed by Lukas
In this FAQ Video Module, Claudia Rivera Salas, NP, a rheumatology nurse practitioner in East Lansing, Michigan, explains how clinicians choose betwee...
Medication Review: Leflunomide Medication Review
14 Aug 2025
Contributed by Lukas
In this educational session, Jessica Farrell, PharmD, from Albany Medical Center and Albany College of Pharmacy and Health Sciences, provides key clin...
RhAPPcast: Spotting the Signs: Recognizing and Diagnosing Giant Cell Arteritis
12 Aug 2025
Contributed by Lukas
In this debut episode of the GCA Fireside Chat series on RhAPPcast, host Amanda Mixon, PA-C, president of Rheumatology Advanced Practice Providers (Rh...
RhAPPcast: Foundations of PMR: Diagnosis, First-Line Therapy, and Tapering Strategies
05 Aug 2025
Contributed by Lukas
In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers (RhAPP), host Amanda Mixon, PA-C, is joined by seasoned...
Journal Club Review: Sarilumab for Relapse of Polymyalgia Rheumatica During Glucocorticoid Taper
22 Jul 2025
Contributed by Lukas
In this journal club episode, Jeannette Hart, PA-C—co-founder of PNW Arthritis and Rheumatology and practicing at Kadlec Regional Medical Center in ...
FAQ: Steroid-Sparing Agent Consideration in PMR Management & What Options Are Available?
15 Jul 2025
Contributed by Lukas
In this FAQ video, Claudia Rivera, NP, a rheumatology nurse practitioner from East Lansing, Michigan, discusses when to consider a steroid-sparing age...
FAQ: What Are the Most Recent Treatment Guidelines for PMR, and What Are the Key Clinical Takeaways?
08 Jul 2025
Contributed by Lukas
In this video, Kyle George, PA-C, a rheumatology physician assistant with St. Luke’s Rheumatology in Idaho, reviews the key clinical takeaways from ...
Medication Review: What is the Mechanism of Action of Methotrexate?
01 Jul 2025
Contributed by Lukas
In this video, clinical pharmacist and RhAPP faculty member Danielle Gatti Palumbo breaks down the mechanism of action of methotrexate, explaining how...
Journal Club Review: A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis
26 Jun 2025
Contributed by Lukas
In this journal club session, Danielle Gatti-Palumbo, PharmD, a clinical pharmacist at Northwell Health Division of Rheumatology, explores the safety ...
RhAPPcast: Understanding the TYK2/STAT Signaling Pathway in PsA: Clinical Implications and Beyond
19 Jun 2025
Contributed by Lukas
In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers (RhAPP), host Amanda Mixon, PA-C, dives into the evolvi...
Medication Review: Hydroxychloroquine Medication Review
17 Jun 2025
Contributed by Lukas
Hydroxychloroquine is a cornerstone therapy in rheumatology, offering significant benefits for mild rheumatoid arthritis (RA) and lupus. In this video...
FAQ: How Does the Selectivity of TYK2 and JAK Enzyme Inhibition Influence Their Safety Profiles
12 Jun 2025
Contributed by Lukas
In this FAQ Video Module, Christy Vath, PA-C, a seasoned rheumatology expert from Seattle Rheumatology Associates, explores how the selectivity of TYK...
FAQ: According to the New 2024 ACR Guidelines for Lupus Nephritis, How Do You Monitor LN?
09 Jun 2025
Contributed by Lukas
Join Monica Richey, NP, with 20+ years of experience in Rheumatology, as she breaks down the latest 2024 ACR guidelines for monitoring lupus nephritis...
FAQ: Can You Recapture Response to IL-17i Therapy After Interruption or Discontinuation in Therapy?
04 Jun 2025
Contributed by Lukas
Join Audrey Gibson, PA-C, a seasoned rheumatology provider at the Arthritis Center of North Georgia with 18 years of clinical experience, as she explo...
FAQ: Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines
29 May 2025
Contributed by Lukas
In this expert-led video, Stacey Johnson, NP-C, from the Montana Arthritis Center, breaks down the 2024 ACR Guidelines for Lupus Nephritis and highlig...
Medication Review: What Is the Safety Profile of Deucravacitinib in PsO and PsA?
26 May 2025
Contributed by Lukas
Join Iris Zink, a rheumatology nurse practitioner with over 25 years of experience, as she explores the safety profile of TYK2 inhibitors, with a focu...
Journal Club Review: Voclosporin in Lupus Nephritis: New Insights on Efficacy & Safety from Clinical Trials
23 May 2025
Contributed by Lukas
Join Danielle Gatti Palumbo, Clinical Pharmacist at Northwell Health Division of Rheumatology, as she presents an integrated analysis of clinical tria...
Medication Review: What is the Mechanism of Action of Deucravacitinib?
19 May 2025
Contributed by Lukas
In this video, Iris Zink, rheumatology nurse practitioner and clinic owner in East Lansing, Michigan, breaks down the mechanism of action of deucravac...
RhAPPcast: Practical Application: Integrating the New ACR LN Guidelines
16 May 2025
Contributed by Lukas
In this episode of RhAPPcast, host Amanda Mixon, PA-C, is joined by Monica Richey, NP, and Danielle Gatti-Palumbo, PharmD, for a practical and engagin...
Medication Review: What is the Real World Evidence of Guslekumab in PsA
14 May 2025
Contributed by Lukas
Join Cassie Dolecki, PharmD, a Clinical Pharmacy Specialist in Rheumatology at Allegheny Health Network in Pittsburgh, Pennsylvania, as she explores t...
FAQ: TYK2/STAT Pathway & Why TYK2 Therapy Works for Psoriasis and Psoriatic Arthritis
09 May 2025
Contributed by Lukas
Join Iris Zink, a seasoned rheumatology nurse practitioner with over 25 years of experience, as she explains the TYK2/STAT signaling pathway and the i...
RhAPPcast: Decoding IL-17: Comparing and Contrasting IL-17A and IL-17F Inhibition
07 May 2025
Contributed by Lukas
Join Amanda Mixon, PA-C, President of RhAPP, as she hosts an insightful discussion with Will Saalfeld, NP, a leading rheumatology expert and RhAPP fac...
Medication Review: What Are the Clinically Meaningful Differences Between Voclosporin and Other Calcineurin Inhibitors?
02 May 2025
Contributed by Lukas
In this video, Jessica Farrell, PharmD—clinical pharmacist at Albany Medical Center and professor at Albany College of Pharmacy and Health Sciences—...
RhAPPcast: ACR Psoriatic Arthritis RhAPPUp Part 3
30 Apr 2025
Contributed by Lukas
Welcome back to RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers (RhAPP). In the final episode of our three-part series cov...
RhAPPcast: ACR Psoriatic Arthritis RhAPPUp Part 2
30 Apr 2025
Contributed by Lukas
Welcome back to RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers. In Part 2 of our Psoriatic Arthritis ACR wrap-up series, ...
RhAPPcast: ACR Psoriatic Arthritis RhAPPUP Part 1
30 Apr 2025
Contributed by Lukas
Welcome to RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers (RhAPP). In this episode, host Amanda Mixon, PA-C, kicks off a ...
RhAPPcast: The Relative Persistency and Effectiveness of Guselkumab in the Real-World
28 Apr 2025
Contributed by Lukas
In this episode of RhAPPcast, Amanda Mixon, PA-C, President of RhAPP, sits down with Kyle George, PA-C, to explore the real-world impact of Guselkumab...
Medication Review: What is the safety profile of voclosporin and how should it be monitored?
24 Apr 2025
Contributed by Lukas
Learn about the safety profile and monitoring requirements of voclosporin for lupus nephritis with Jessica Farrell, PharmD, an experienced rheumatolog...
Journal Club Review: Evaluating the Efficacy of Biologic With and Without Methotrexate
22 Apr 2025
Contributed by Lukas
Join Danielle Gatti Palumbo, PharmD, a clinical pharmacist, RhAPP faculty member, and RhAPP Board member, as she breaks down a network meta-analysis e...
Journal Club Review: Voclosporin for Lupus Nephritis: Efficacy & Safety Insights from AURORA 1 & 2 Trials
18 Apr 2025
Contributed by Lukas
Join Jessica Farrell, PharmD, professor at the Albany College of Pharmacy and Health Sciences and clinical pharmacist at Albany Medical Center, as she...
Medication Review: Voclosporin Dosing, Administration, Adjustments & Interactions
17 Apr 2025
Contributed by Lukas
Join Danielle Gatti Palumbo, Clinical Pharmacist at Northwell Health’s Division of Rheumatology in Long Island, New York, as she provides a comprehe...
Medication Review: What is the Efficacy of Guselkumab Across the GRAPPA Domains
16 Apr 2025
Contributed by Lukas
In this expert breakdown, Cassie Dolecki, PharmD, a clinical pharmacy specialist in rheumatology at Allegheny Health Network in Pittsburgh, Pennsylvan...
FAQ: Are IL-17 Inhibitors Efficacious in Treating the Nail-DIP Complex in PsA?
09 Apr 2025
Contributed by Lukas
In this expert discussion, Katie Springer, PA-C, a rheumatology specialist with Northwestern Medicine in Chicago, Illinois, explores the effectiveness...
FAQ: What Are CNIs? Treating Lupus Nephritis with the Latest ACR Guidelines
01 Apr 2025
Contributed by Lukas
In this video, Lisa Asfahani, PA-C, shares clinical insights on the evolving role of calcineurin inhibitors (CNIs) in the treatment of lupus nephritis...
RhAPPcast: Elevating Care in LN: What the New ACR Guidelines Mean for Patients & How APPs can Apply Them
27 Mar 2025
Contributed by Lukas
In this essential episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, is joined by lupus ...
FAQ: How do IL-23 and IL-17 Inhibitors Differ in Clinical Efficacy
25 Mar 2025
Contributed by Lukas
Join Audrey Gibson, PA-C, from the Arthritis Center of North Georgia, as she explores the latest clinical comparisons between IL-17 and IL-23 inhibito...